HIGH TIDE INC (HITI.CA) Stock Fundamental Analysis
Canada - TSX-V:HITI - CA42981E4013 - Common Stock
4.27 CAD
-0.14 (-3.17%)
Taking everything into account, HITI scores 4 out of 10 in our fundamental rating. HITI was compared to 31 industry peers in the Pharmaceuticals industry. The financial health of HITI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, HITI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
HITI had negative earnings in the past year.
In the past year HITI had a positive cash flow from operations.
HITI had negative earnings in each of the past 5 years.
HITI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.76%, HITI is in line with its industry, outperforming 54.84% of the companies in the same industry.
The Return On Equity of HITI (-6.93%) is comparable to the rest of the industry.
HITI has a better Return On Invested Capital (4.61%) than 77.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROIC | 4.61% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HITI has a better Operating Margin (2.30%) than 67.74% of its industry peers.
HITI has a worse Gross Margin (25.83%) than 74.19% of its industry peers.
HITI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HITI is destroying value.
HITI has more shares outstanding than it did 1 year ago.
HITI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HITI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.32 indicates that HITI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.32, HITI belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
HITI has a debt to FCF ratio of 4.08. This is a neutral value as HITI would need 4.08 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 4.08, HITI belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
HITI has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
HITI has a Debt to Equity ratio of 0.43. This is in the lower half of the industry: HITI underperforms 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 3.32 |
ROIC/WACC0.59
WACC7.79%
2.3 Liquidity
HITI has a Current Ratio of 1.85. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HITI (1.85) is comparable to the rest of the industry.
A Quick Ratio of 1.29 indicates that HITI should not have too much problems paying its short term obligations.
The Quick ratio of HITI (1.29) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for HITI have decreased strongly by -328.07% in the last year.
HITI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.18%.
Measured over the past years, HITI shows a very strong growth in Revenue. The Revenue has been growing by 75.59% on average per year.
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
3.2 Future
The Earnings Per Share is expected to grow by 74.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.53% on average over the next years. This is quite good.
EPS Next Y-12.22%
EPS Next 2Y104.72%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue Next Year13.75%
Revenue Next 2Y21.31%
Revenue Next 3Y17.79%
Revenue Next 5Y15.53%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 30.93, HITI can be considered very expensive at the moment.
74.19% of the companies in the same industry are more expensive than HITI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.50, HITI is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 30.93 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HITI is valued a bit cheaper than 67.74% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HITI indicates a somewhat cheap valuation: HITI is cheaper than 70.97% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.91 | ||
| EV/EBITDA | 10.73 |
4.3 Compensation for Growth
HITI's earnings are expected to grow with 96.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y104.72%
EPS Next 3Y96.71%
5. Dividend
5.1 Amount
HITI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:HITI (10/29/2025, 7:00:00 PM)
4.27
-0.14 (-3.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners6.97%
Inst Owner ChangeN/A
Ins Owners8.32%
Ins Owner ChangeN/A
Market Cap372.47M
Revenue(TTM)568.25M
Net Income(TTM)-9797000
Analysts80
Price Target7.33 (71.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)194.66%
Min EPS beat(2)-8%
Max EPS beat(2)397.33%
EPS beat(4)1
Avg EPS beat(4)15.55%
Min EPS beat(4)-315.76%
Max EPS beat(4)397.33%
EPS beat(8)5
Avg EPS beat(8)75.15%
EPS beat(12)9
Avg EPS beat(12)61.94%
EPS beat(16)12
Avg EPS beat(16)45.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.49%
Revenue beat(16)13
Avg Revenue beat(16)7.4%
PT rev (1m)-7.26%
PT rev (3m)2.68%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-27.27%
Revenue NQ rev (1m)4.57%
Revenue NQ rev (3m)6.53%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 30.93 | ||
| P/S | 0.66 | ||
| P/FCF | 18.91 | ||
| P/OCF | 12.74 | ||
| P/B | 2.63 | ||
| P/tB | 7.17 | ||
| EV/EBITDA | 10.73 |
EPS(TTM)-0.13
EYN/A
EPS(NY)0.14
Fwd EY3.23%
FCF(TTM)0.23
FCFY5.29%
OCF(TTM)0.34
OCFY7.85%
SpS6.51
BVpS1.62
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROCE | 6.4% | ||
| ROIC | 4.61% | ||
| ROICexc | 6.71% | ||
| ROICexgc | 18.48% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% | ||
| FCFM | 3.47% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score5
Asset Turnover2.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 1.67 | ||
| Cap/Depr | 41.17% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 3.32 |
F-Score5
WACC7.79%
ROIC/WACC0.59
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-12.22%
EPS Next 2Y104.72%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
Revenue Next Year13.75%
Revenue Next 2Y21.31%
Revenue Next 3Y17.79%
Revenue Next 5Y15.53%
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year418.19%
EBIT Next 3Y133.23%
EBIT Next 5Y81.08%
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.53%
OCF growth 3YN/A
OCF growth 5YN/A
HIGH TIDE INC / HITI.CA FAQ
What is the fundamental rating for HITI stock?
ChartMill assigns a fundamental rating of 4 / 10 to HITI.CA.
What is the valuation status of HIGH TIDE INC (HITI.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to HIGH TIDE INC (HITI.CA). This can be considered as Overvalued.
Can you provide the profitability details for HIGH TIDE INC?
HIGH TIDE INC (HITI.CA) has a profitability rating of 2 / 10.
What is the financial health of HIGH TIDE INC (HITI.CA) stock?
The financial health rating of HIGH TIDE INC (HITI.CA) is 5 / 10.
Can you provide the expected EPS growth for HITI stock?
The Earnings per Share (EPS) of HIGH TIDE INC (HITI.CA) is expected to decline by -12.22% in the next year.